Literature DB >> 24999215

Obstructive jaundice and perioperative management.

Long Wang1, Wei-Feng Yu2.   

Abstract

The causes of obstructive jaundice are varied, but it is most commonly due to choledocholithiasis; benign strictures of the biliary tract; pancreaticobiliary malignancies; and metastatic disease. Surgery in patients with obstructive jaundice is generally considered to be associated with a higher incidence of complications and mortality. Therefore, it poses a considerable challenge to the anesthesiologist, surgeons, and the intensive care team. However, appropriate preoperative evaluation and optimization can greatly contribute to a favorable outcome for perioperative jaundiced patients. This article outlines the association between obstructive jaundice and perioperative management, and reviews the clinical and experimental studies that have contributed to our knowledge of the underlying pathophysiologic mechanisms. Pathophysiology caused by obstructive jaundice involving coagulopathies, infection, renal dysfunction, and other adverse events should be fully assessed and reversed preoperatively. The depressed cardiovascular effects of obstructive jaundice are worth noticing because it has complicated mechanisms and needs to be further explored. Alterations of anesthesia-related drugs induced by obstructive jaundice are varied and clinicians should be aware of the possible need for a decrease in the anesthetic dose. Recommendations concerning the perioperative management of the patients with obstructive jaundice including preoperative biliary drainage, anti-infection, nutrition support, coagulation reversal, cardiovascular evaluation, perioperative fluid therapy, and hemodynamic optimization should be taken.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  anesthesia; cardiovascular system; jaundice, obstructive; perioperative care

Mesh:

Substances:

Year:  2014        PMID: 24999215     DOI: 10.1016/j.aat.2014.03.002

Source DB:  PubMed          Journal:  Acta Anaesthesiol Taiwan


  7 in total

1.  Dexmedetomidine activates the PI3K/Akt pathway to inhibit hepatocyte apoptosis in rats with obstructive jaundice.

Authors:  Yaying Xie; Chunyan Guo; Ye Liu; Luanyuan Shi; Jianshe Yu
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

2.  Comparative Study of the Results of Operations in Patients with Tumor and Non-Tumor Obstructive Jaundice Who Received and Did Not Receive Antioxidant Therapy for the Correction of Endotoxemia, Glycolysis, and Oxidative Stress.

Authors:  Victor Stupin; Igor Abramov; Teymur Gahramanov; Alexey Kovalenko; Natalia Manturova; Petr Litvitskiy; Zalim Balkizov; Ekaterina Silina
Journal:  Antioxidants (Basel)       Date:  2022-06-20

3.  Bilirubin modulates acetylcholine receptors in rat superior cervical ganglionic neurons in a bidirectional manner.

Authors:  Chengmi Zhang; Zhenmeng Wang; Jing Dong; Ruirui Pan; Haibo Qiu; Jinmin Zhang; Peng Zhang; Jijian Zheng; Weifeng Yu
Journal:  Sci Rep       Date:  2014-12-15       Impact factor: 4.379

4.  Altered expression of differential gene and lncRNA in the lower thoracic spinal cord on different time courses of experimental obstructive jaundice model accompanied with altered peripheral nociception in rats.

Authors:  Qian Wang; Zhi-Xiao Li; Bao-Wen Liu; Zhi-Gang He; Cheng Liu; Min Chen; San-Guang Liu; Wei-Zhong Wu; Hong-Bing Xiang
Journal:  Oncotarget       Date:  2017-11-20

5.  Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: A retrospective observational study.

Authors:  Hao Jin; Qing Pang; Huichun Liu; Zongkuang Li; Yong Wang; Yimin Lu; Lei Zhou; Hongtao Pan; Wei Huang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

6.  Biliary Leakage Following Pancreatoduodenectomy: Experience from a High-Volume Center.

Authors:  Waqas Farooqui; Luit Penninga; Stefan Kobbelgaard Burgdorf; Jan Henrik Storkholm; Carsten Palnæs Hansen
Journal:  J Pancreat Cancer       Date:  2021-12-24

7.  Percutaneous biliary stent combined with brachytherapy using 125I seeds for treatment of unresectable malignant obstructive jaundice: A meta-analysis.

Authors:  Wei-Yue Chen; Chun-Li Kong; Miao-Miao Meng; Wei-Qian Chen; Li-Yun Zheng; Jian-Ting Mao; Shi-Ji Fang; Li Chen; Gao-Feng Shu; Yang Yang; Qiao-You Weng; Min-Jiang Chen; Min Xu; Jian-Song Ji
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.